Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2023 Earnings Call Transcript
Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.12.
Source: insidermonkey.com
📰 Dare Bioscience News
Dare Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dare Bioscience. Real-time updates on events, politics, business and more.
Earnings Scheduled For March 28, 2024 - Ascent Industries (NASDAQ:ACNT), Achieve Life Sciences (NASDAQ:ACHV)
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.
Source: benzinga.com
DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023
Dare Bioscience (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…
Source: biztoc.com
Dare Bioscience to Lose Two Executives, Directors
By Dean Seal The chief financial officer and chief commercial officer of Dare Bioscience are leaving the company, as are two of its directors. The San...
Cheryl Blanchard Lisa Walters Hoffert Sabrina Martucci Johnson Sophia Ononye Onyia Mardee Haring Layton Dare Bioscience
Source: marketwatch.com
DARE Stock Price | Dare Bioscience Inc. Stock Quote (U.S.: Nasdaq)
DARE | Complete Dare Bioscience Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Source: marketwatch.com
Daré Bioscience, Inc. (NASDAQ:DARE) Q3 2023 Earnings Call Transcript
Operator: Welcome to the conference hosted by Daré Bioscience to Review the Companys Third Quarter Financial Results and to provide a General Business Update. This call is being recorded.
United States Catherine Novack Sabrina Martucci Johnson Lisa Walters Hoffert Clinical Trials Network National Institute Of Child Health
Source: insidermonkey.com
Dare Bioscience Stock (NASDAQ:DARE), Quotes and News Summary
Dare Bioscience Stock (NASDAQ: DARE) stock price, news, charts, stock research, profile.
Source: benzinga.com
Daré Bioscience Announces Availability of Publication on the Patient-Centered Concept Elicitation Study for Female Sexual Arousal Disorder in The Journal of Sexual Medicine
31.05.2023 - The Concept Elicitation Study Informed the Selection of the Primary, Secondary, and Exploratory Endpoints Included in the Phase 2b RESPOND Clinical Study Evaluating the Efficacy and Safety of Sildenafil Cream, 3.6% in Premenopausal Patients with ... Seite 1
Source: wallstreet-online.de
Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2023 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended March 31, 2023, and to provide a General Business Update.
Source: insidermonkey.com
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2022 Earnings Call Transcript
Operator: Welcome to the conference call hosted by Daré Bioscience to review the companys Financial Results for the Year Ended December 31, 2022 and to provide a general business update.
United States Lisa Walters Hoffert Catherine Novack Sabrina Johnson Sabrina Martucci Johnson Dare Bioscience Inc
Source: insidermonkey.com